A Randomized, Double-blind and Parallel Group Study to Compare the Pharmacokinetic, Safety and Pharmacodynamic of QL1206 and Prolia® in Healthy Adults
Latest Information Update: 02 Dec 2021
At a glance
- Drugs Denosumab (Primary)
- Indications Bone metastases; Postmenopausal osteoporosis
- Focus Pharmacokinetics
- Sponsors Qilu Pharmaceutical
Most Recent Events
- 02 Jan 2020 New trial record